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What is already known about this subject? 
- Non-alcoholic fatty liver disease (NAFLD) is a common condition with few 
available treatments. 
- Guidelines recommend increasing physical activity in patients with NAFLD. 
- Most prior studies utilize subjective measures of physical activity. 
 
What does this study add? 
- There is an inverse association between objectively measured physical activity, 
outside of a structured exercise intervention, and hepatic steatosis. 
- Compliance with national physical activity guidelines may be associated with less 
hepatic steatosis.   
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Abstract:  
Objective: Prior studies on the association of physical activity (PA) and non-alcoholic 
fatty liver disease are limited by reliance on subjective measures of PA.  We examined 
the association between objectively measured PA and hepatic steatosis defined by 
computed tomography (CT).  Methods: We conducted a cross-sectional study of 1060 
Framingham Heart Study participants who participated in the Multi-Detector CT 2 
substudy and who underwent assessment of PA via accelerometry. Hepatic steatosis 
was estimated by liver attenuation, as measured by CT. We explored the relationship 
between liver attenuation and PA using multivariable regression models. Results: In 
multivariable-adjusted models, we observed an inverse association between PA and 
liver attenuation. Each 30 min/day increase in moderate-to-vigorous PA (MVPA) was 
associated with a reduced odds of hepatic steatosis (OR=0.62, p<0.001). This 
association was attenuated and no longer statistically significant after adjustment for 
BMI (OR=0.77, p=0.05) or VAT (OR=0.83, p=0.18). Participants who met the national 
PA recommendations of engaging in ≥150 minutes/week of MVPA, had the lowest odds 
of hepatic steatosis, even after adjusting for BMI (OR=0.63, p=0.007) or VAT (OR=0.67, 
p=0.03).  Conclusions:  There is an inverse association between PA and hepatic 
steatosis. Participants who met the national PA guidelines had the lowest prevalence of 
hepatic steatosis. 
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Introduction 
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver 
disease in the United States.(1)  NAFLD refers to a broad spectrum of liver injury from 
simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis.  Large population 
based studies have demonstrated associations between NAFLD and increased all-
cause and liver-related mortality;(2, 3) however, there are no medical therapies 
available.      
Currently, the cornerstone of treatment for NAFLD involves lifestyle interventions 
including increasing physical activity (PA).(4) The relationship between PA and NAFLD, 
independent of weight loss, has not been well characterized. In several small studies of 
exercise programs, liver fat content diminishes (5, 6, 7) and intrahepatic triglyceride 
content decreases (8) with exercise independent of weight loss. A randomized 
controlled trial in obese patients found that the addition of physical activity to a diet-
induced weight loss program promoted greater reductions in waist circumference and 
hepatic fat content.(9) The literature is still somewhat conflicting, as some studies show 
no improvement in histologic features of NASH with circuit exercise training.(10) The 
optimal dose of PA by intensity and duration for the prevention and treatment of NAFLD 
has not been well established.  Prior population-based studies of the association of PA 
and NAFLD have been limited by the lack of objectively obtained PA data, with most 
studies relying on self-report, patient recall or leisure time only activities.(11, 12, 13, 14) 
The one population based study using accelerometer derived physical activity 
measurements found that participants with NAFLD were less physically active than 
participants without NAFLD. (15)  However, this study defined NAFLD based on the 
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Fatty Liver Index which does not incorporate imaging data and has been shown to have 
limited utility in detecting hepatic steatosis in obese patients.(16) In addition, there is 
emerging evidence that prolonged sedentary time, independent of PA, may be 
associated with cardiometabolic risk factors and overall mortality, but the associations 
with NAFLD has not been specifically evaluated.(17, 18, 19)   
Thus, the purpose of the present study was to determine the association 
between objectively measured PA using accelerometry and hepatic steatosis in a large 
community-based sample.  We hypothesized that participants with higher levels of PA 
would have a lower prevalence of hepatic steatosis.  We also evaluated whether an 
association exists between sedentary time and hepatic steatosis.  Finally, we assessed 
whether associations were stronger in participants who met the national PA guidelines 
of ≥150 minutes of moderate-to-vigorous PA (MVPA) per week in total or accumulated 
in bouts of ≥10 minutes.(20)   
Patients and Methods 
Additional methodological details are available in the online supplement. 
Study sample 
The Framingham Heart Study (FHS) is a multi-generational cohort study.  Our 
sample was derived from a total of 3732 participants in the Third Generation Cohort and 
Omni 2 Cohort of the FHS who attended the second examination cycle (May 2008 to 
March 2011) when accelerometry was performed.  Individuals were excluded from this 
analysis if they did not participate in the Multi-Detector CT 2 substudy (n=2162) or their 
CT scans were not interpretable for liver attenuation or Visceral Adipose Tissue (VAT) 
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(n=14), they did not participate in accelerometry (n=239) or had insufficient 
accelerometry data (n=75), they had missing serum aminotransferase levels (n=5), 
incomplete covariate data (n=1) or significant alcohol use defined as > 7 drinks per 
week for women and > 14 drinks per week for men (n=176), yielding a total sample of 
1,060 participants.  The institutional review boards of the Boston University Medical 
Center and Massachusetts General Hospital approved the study protocol.   
Measurement of physical activity by accelerometer 
 During the second examination cycle between May 2008 to March 2011, Third 
Generation and Omni Cohort 2 participants were instructed to wear an omnidirectional 
accelerometer (Actical Model No. 198-0200-00; Philips Respironics, Bend, OR) on a 
waist-worn belt 24 hours/day for 8 days (to allow for 7 full days of wear time) as 
previously described.(21)   
Multi-detector CT scan protocol and measurement of VAT and liver attenuation 
Multi-detector CT scans were conducted in a substudy of FHS participants from 
September 2008 to December 2011 as previously described.(22)  We defined hepatic 
steatosis as a liver phantom ratio of ≤ 0.33 based our prior work.(23) 
Covariate and baseline measurements  
Covariate and baseline measurements were measured at the second 
examination cycle (May 2008 to March 2011) for the Third Generation and Omni Cohort 
2 participants when accelerometry was also routinely performed.   
Statistical analysis 
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 To describe the characteristics of the analysis population, we used means with 
standard deviations for continuous traits and percentages for categorical traits.  Sex-
specific, age-adjusted Pearson correlation coefficients between PA categories 
(sedentary, light, MVPA and MVPA bouts) and metabolic parameters were calculated.  
Multivariable logistic regression models were used to assess the cross-sectional 
association with PA (per 30 minutes/day increase in PA or compliance with national PA 
guidelines) and hepatic steatosis as measured by multi-detector CT scan.  An additional 
multivariable logistic regression model examining the association between sedentary 
time and hepatic steatosis was performed.  For each dependent variable, three 
separate models were calculated.  Model 1 adjusted for age, sex, cohort (Third 
Generation vs Omni), current smoking status, alcohol use (drinks/week), accelerometer 
“wear time” in days; for the analysis examining the association between sedentary time 
and hepatic steatosis, we additionally adjusted for light PA and MVPA minutes/day. The 
second model contained the same covariates from model 1 and additionally adjusted for 
BMI.  Model 3 adjusted for the covariates in model 1 and additionally adjusted for VAT.  
We also tested for effect modification by sex in the primary model. 
To explore the association of PA and aminotransferase levels, multivariable-
adjusted linear regression models examining the association between log-adjusted ALT 
and AST per 30 minutes/day increase in PA were performed.  ALT and AST were 
natural log-transformed to normalize their skewed distribution.   
Since hepatic steatosis is associated with obesity, we further characterized the 
association between MVPA, hepatic steatosis and BMI, by stratifying participants by 
BMI category (normal BMI (BMI < 25 kg/m2), overweight (25 kg/m2 ≤ BMI < 30 kg/m2) 
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and obese (BMI ≥ 30 kg/m2)). We used the t-test for differences in means to determine if 
there were differences in the mean MVPA among those with hepatic steatosis (LPR ≤ 
0.33) and those without hepatic steatosis (LPR > 0.33) across the BMI categories and 
for obese (BMI ≥ 30 kg/m2) vs non-obese (BMI < 30 kg/m2) participants.   
A sensitivity analysis was conducted to assess the effect of using a less stringent 
definition of heavy alcohol use (defined as >14 drinks per week for women and >21 
drinks per week for men) recommended by the American Association for the Study of 
Liver Diseases guidelines.(4)   
Analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC) 
software.  A 2-tailed P value of < 0.05 was considered significant. 
Results 
Study sample characteristics 
The characteristics of the study sample (mean age 50.5 ± 7.2 yrs, 47.3% 
women), by sex, are depicted in Table 1.  On average, participants were overweight 
(mean BMI 28.4 ± 5.4 kg/m2) and 22.0% of women and 32.0% of men had a LPR ≤ 0.33 
consistent with hepatic steatosis.  On average, participants accumulated nearly 30 
minutes/day of MVPA (26.6 ± 20.4 minutes of MVPA per day) and 14.5 ± 14.3 minutes 
of MVPA in bouts, defined as continuous MVPA of at least 10 minutes. Only 14.0% of 
women and 10.6% of men met the strict PA guideline of participating in ≥150 
minutes/week of MVPA in bouts, while about 50% of participants engaged in ≥150 
minutes/week of total MVPA.  The average number of sedentary hours per day was 
11.1 ± 1.1 (which excludes 8 hours of sleep) (Table 1).  After adjusting for age, as 
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expected, there was a moderate, positive correlation between more liver fat (- LPR) and 
VAT (r=0.50, p<0.0001). 
Correlations between accelerometer derived physical activity and metabolic parameters 
 MVPA minutes/day was associated with most adiposity traits in women and men 
(Table 2).  Specifically, increasing MVPA minutes/day was associated with lower BMI in 
women only (p<0.001), waist circumference, and VAT volume and a higher liver 
attenuation (less liver fat) and log AST (all p<0.05).  Sedentary time was associated with 
VAT volume and log AST (p<0.05) for women only. 
Multivariable-adjusted regression models relating hepatic steatosis to physical activity 
 In multivariable-adjusted models, there was an inverse association between PA 
and hepatic steatosis (LPR ≤ 0.33) (Table 3).  Specifically, each 30 minute per day 
increase in MVPA was associated with a reduced odds of hepatic steatosis (OR= 0.62, 
p<0.001).  This association was attenuated and marginally significant after adjustment 
for BMI (OR = 0.77, p=0.05) and no longer significant after adjustment for VAT (OR = 
0.83, p=0.18).  Similar associations were found for MVPA performed in bouts. There 
was a significant sex interaction suggesting that associations between these factors 
was stronger in women compared to men (Table 3). 
 
Multivariable-adjusted regression models relating hepatic steatosis to compliance with 
national physical activity guidelines 
 11 
For participants who met the national PA recommendations of engaging in ≥150 
minutes/week of MVPA, the odds of hepatic steatosis was lower compared to those not 
meeting these recommendations, even after adjusting for BMI (OR=0.63, p=0.007) or 
VAT (OR=0.67, p=0.03) (Table 4).  We found a significant sex interaction (p=0.02).  The 
magnitude of the association of reduced odds of hepatic steatosis among participants 
compliant with the national PA guidelines was greater in women than in men, and 
remained statistically significant after adjustment for BMI or VAT in women only.     
 
Multivariable-adjusted regression models relating hepatic steatosis to sedentary time 
There was not a statistically significant association between sedentary time and 
hepatic steatosis in any of the regression models (Supplementary Table 1).     
 
Association between aminotransferase levels and physical activity 
 There were no associations with log ALT and increasing amounts of PA across 
all activity categories (Supplementary Table 2).  However, for AST, for every 30 minute 
increase in MVPA minutes/day or MVPA bouts minutes/day and for those meeting the 
national PA guidelines, a significant positive association with log AST was observed.   
 
Association of physical activity and hepatic steatosis by BMI category 
 The number of MVPA minutes/day accumulated per participant according to 
hepatic steatosis and BMI category are shown in Figure 1.  Participants with hepatic 
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steatosis performed the least amount of MVPA minutes/day within BMI categories; 
however, the difference was only statistically significant in the overweight BMI category 
(p=0.02; MVPA normal weight hepatic steatosis vs non-hepatic steatosis p=0.25; MVPA 
obese hepatic steatosis vs non-hepatic steatosis p=0.48).  Non-obese participants (BMI 
< 30 kg/m2) without hepatic steatosis (n=609) performed more MVPA minutes/day (29.3 
min/day) compared to non-obese participants with hepatic steatosis (n=102) (22.6 
min/day) (p=0.002). 
 
Secondary Analysis 
 A secondary analysis adjusting the exclusion criteria to use a less stringent 
definition of heavy alcohol use(4) was performed and the results of multivariable 
regression models were essentially unchanged (data not shown).     
 
Discussion 
Principle findings 
 In this cross-sectional study in a large, unselected, community-based cohort, our 
findings are 3-fold.  First, we observed that participants who engaged in higher levels of 
PA were less likely to have prevalent hepatic steatosis.  Second, compliance with 
national PA guidelines was associated with the lowest odds of hepatic steatosis even in 
models adjusting for BMI.  The magnitude of this association was stronger in women 
compared to men and remained statistically significant after adjusting for BMI or VAT in 
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women only.  Finally, there were no associations between sedentary time and hepatic 
steatosis.     
In the context of the current literature 
 There have been a number of small studies in select populations which have 
demonstrated improvements in hepatic steatosis in participants of structured exercise 
and weight loss programs.(5, 6, 7, 8, 9) Little is currently known about the association of 
physical activity, outside of structured interventions, and NAFLD. Prior studies 
evaluating the association between PA and NAFLD have largely relied on self-reported 
PA assessments and our findings are in line with this prior work.(11, 12, 13, 14)  Self-
reported PA data can be hampered by recall and response bias as well as the inability 
to accurately quantify PA levels.(24, 25)  To our knowledge, there has been only one 
other population-based study investigating objectively-measured PA and NAFLD that 
was conducted with the National Health and Nutrition Examination Survey (NHANES) 
data using a surrogate measure of NAFLD, the fatty liver index.(15)  This study found 
an association between NAFLD and lower PA in age- and sex-adjusted models.  Our 
investigation advances the current literature by demonstrating that the association 
between hepatic steatosis and lower PA remains statistically significant after 
adjustments in a multivariable regression model, including BMI or VAT, but only for 
participants that engaged in ≥150 minutes per week of MVPA.  This finding may indicate 
that there is a threshold of MVPA that must be exceeded before there are significant 
effects on liver fat.  Additionally, our investigation further examined sedentary time and 
found no association with hepatic steatosis.   
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The current national guidelines for PA for all Americans recommend at least 150 
minutes of moderate PA a week or 75 minutes of vigorous activity a week or a 
combination of both accrued in bouts of at least 10 minutes to improve and maintain 
health (20).  There has been very little prior work specifically evaluating these guidelines 
in NAFLD.  In a cohort of biopsy proven NAFLD, subjects who met vigorous activity 
recommendations had a significantly decreased adjusted-odds of NASH compared to 
those who did not meet the vigorous activity recommendations.(12)  This association 
was not seen for subjects who met the moderate-intensity PA recommendations.  The 
authors conclude that intensity of PA, specifically vigorous activity, may be more 
important than duration or total volume of activity for the prevention or treatment of 
NASH.  However, this study was limited by the use of self-reported leisure time only PA 
which tends to over-report MVPA and under-report sedentary time compared with 
objectively measured, accelerometer derived, PA measurements.(25, 26)  The amount 
of vigorous activity that participants in this study reported is likely an over-estimate since 
26% of the sample met the vigorous PA guidelines, while in our investigation and others 
using accelerometer derived PA measurements, only 5.5% of participants met the 
vigorous PA guidelines.(26)  By using an accelerometer derived assessment of PA, we 
have evaluated an objective measure of adherence to the national PA guidelines. 
We observed no association between sedentary time and hepatic steatosis 
which, to our knowledge, has not been previously demonstrated.  Prior population-
based studies have shown lower mortality from diabetes, cardiovascular disease and 
all-cause mortality with less sedentary time after adjusting for self-reported PA.(17, 18, 
19)  There is evidence that interrupting sedentary time with 2 minute bouts of light or 
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moderate activity every 20 minutes may decrease postprandial glucose and insulin 
levels in overweight and obese adults.(27)  We did not evaluate the effects of 
interrupted versus continuous sedentary time on hepatic steatosis, but this might be an 
interesting area of future investigation.   
Potential mechanisms 
 Evidence from animal and human studies supports a benefit of exercise on 
hepatic fat content as well as skeletal muscle and adipose tissue deposits.(28)  In 
humans, exercise reduces plasma free fatty acids and decreases intrahepatic 
triglyceride content independent of weight loss.(5, 8) Additionally, exercise likely also 
enhances insulin sensitivity in skeletal muscle thereby reducing insulin resistance which 
is highly correlated with NAFLD.(29)  Exercise may also contribute to differences in fatty 
acid uptake and utilization in the liver.  Regular exercise increases the capacity for fatty 
acid uptake and oxidation within skeletal muscle which may help decrease the fatty acid 
burden in other tissues, including hepatocytes.(30) Furthermore, exercise may directly 
augment hepatic fat by altering insulin-mediated intracellular utilization of fatty 
acids.(31) 
 We found significant sex interactions for hepatic steatosis and MVPA accrued in 
bouts and compliance with national PA guidelines where the effects were stronger in 
women compared to men.  It is well-established that women and men have differences 
in fat distribution, with women having relatively lower VAT and higher SAT compared to 
men.(32, 33) Additionally, increasing VAT and SAT volumes are associated with more 
adverse cardiovascular risk factors in women compared to men.(32) Women have 
greater free fatty acid concentration and turn over compared to men which suggests sex 
 16 
differences in adipose tissue lipolysis.(34) Prior population based studies have 
demonstrated sex differences in NAFLD prevalence. In a study which defined NAFLD 
based on ultrasound, men had a higher prevalence of NAFLD compared to women in 
adjusted models.(35) Additionally, in the Dallas Heart Study  which measured hepatic 
triglyceride content on magnetic resonance imaging, non-Hispanic white men had a 2-
fold increased risk of fatty liver compared to non-Hispanic white women.(36) This 
increased risk in men was not attributable to differences in body weight or insulin 
sensitivity and was not demonstrated in other ethnic groups.(36)  It is not known if 
differential effects of physical activity contribute to sex differences in hepatic steatosis. 
Prior studies evaluating sex differences on the effects of physical activity or exercise on 
fat metabolism are very limited.(30, 37) In one small study, women were found to 
oxidize proportionally more lipid and less carbohydrate during exercise compared to 
men both before and after a 7 week endurance training program.(38)  It is possible that 
sex difference in exercise induced lipolysis may contribute to the overall stronger 
associations with PA and reduced prevalence of hepatic steatosis among women 
compared to men in our study.(31)  More research on potential sex differences of PA on 
hepatic steatosis are needed to further understand this interaction.   
Implications 
The intensity, amount and duration of PA required for the prevention and 
treatment of NAFLD is an important outstanding question since lifestyle modification 
remains the cornerstone of treatment.(4)  Currently, there is no standardized 
recommendation for PA in NAFLD patients.  Although cross sectional, our investigation 
gives support for suggesting that compliance with the national PA guidelines of at least 
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150 minutes of moderate PA per week may be associated with less hepatic steatosis.    
Without objective measures, individuals may over-estimate their own physical activity, 
with larger differences between self-reported and accelerometer measured MVPA with 
higher levels of activity.(25) In practice, it is possible that an individual may report that 
they meet the national PA guidelines; however, when their activity is measured 
objectively, they may no longer meet guideline recommendations.   
Strengths and limitations 
 The major strengths of our investigation include the use of a well-established and 
objective measure of PA.  By taking advantage of a well-characterized, community-
based sample, with standardized demographic, laboratory and anthropometric 
measurements, we are able to add to the current literature by adjusting for several 
important confounders in exploring the association with PA and hepatic steatosis.  
Additionally, our community based sample has not been selected for hepatic steatosis.   
 There are a number of important limitations to our investigation that deserve 
mention.  First, this is a cross-sectional, observational study and therefore we cannot 
evaluate temporality and cannot make inferences about causality.  Although 
accelerometry is a well-established measure of PA, because it is worn on the hip, it is 
has a limited ability to measure activities that are performed while the hip is stationary, 
such as swimming or bicycle riding, which may have resulted in non-differential 
misclassification, which would bias towards the null.  Additionally, the temporally fixed 
sleep time appropriation methods may not fully represent the specific accelerometer 
wear patterns of the participants.  An important assumption to acknowledge is that the 
majority of participants would be sleeping between the hours of 2200 and 0600 and we 
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did not want this sedentary time to be counted with wakeful sedentary time. We 
estimated liver attenuation via CT imaging, which likely underrepresents the burden of 
hepatic steatosis in the population since CT imaging is non-specific and insensitive to 
mild steatosis compared to the gold standard of liver biopsy.(39) This may have led to 
non-differential misclassification, biasing our results towards the null.  Therefore, our 
findings may underrepresent the true association between hepatic steatosis and 
physical activity. Additionally, since CT scan lacks the sensitivity to detect mild liver 
steatosis (<30% fat content), our study cannot evaluate the association between mild 
hepatic steatosis and physical activity. Since the LPR has a sensitivity of 70% for 
hepatic steatosis (23), this also has the potential to lead to non-differential 
misclassification, biasing our results towards the null. Additionally, CT imaging cannot 
accurately detect steatohepatitis so we are unable to determine the association of PA 
on fatty liver disease severity.  Hepatic fat content can fluctuate rapidly with exercise 
and changes in weight.  In this cross-sectional study, we are not able to measure the 
effects of PA and liver attenuation directly. We also lack information about viral hepatitis 
status and other chronic liver conditions which can cause the appearance of liver fat on 
CT scan.  The seropositivity of hepatitis C is low in the general population (1-2%) so the 
possibility of confounding because of chronic hepatitis C in our population is low.(40)  
Additionally, our sample is overwhelming Caucasian so the generalizability of our 
findings to individuals of non-European ancestry is not known.   
Conclusion 
 In conclusion, we observed an inverse association between MVPA and hepatic 
steatosis.  Participants who met the national PA guideline recommendations of 
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engaging in at least 150 min/week of MVPA had a lower odds of hepatic steatosis, 
compared to those not reaching guideline recommendations.  Future longitudinal 
studies using objectively measured PA assessments are required to further explore the 
role of PA for the prevention and treatment of hepatic steatosis.   
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Figure and Table Legends: 
 
Table 1:  
MVPA indicates moderate-to-vigorous physical activity; BMI, body mass index; ALT, 
alanine aminotransferase; AST, aspartate aminotransferase.  Data are presented as the 
mean (SD) for continuous traits and percentage having that characteristic for categorical 
data.   
*A bout of MVPA is defined as at least 10 minutes of continuous MVPA allowing for a 2 
minute interruption.   
Table 2: 
MVPA indicates moderate-to-vigorous physical activity; BMI body mass index; VAT, 
visceral adipose tissue; ALT, alanine aminotransferase; AST, aspartate 
aminotransferase. 
*P-value < 0.05 
**p-value < 0.01 
***p-value < 0.001 
†A bout of MVPA is defined as at least 10 minutes of continuous MVPA allowing for a 2 
minute interruption. 
Table 3: 
BMI indicates body mass index; VAT, visceral adipose tissue 
*Multivariable (MV) Model includes age, sex (in overall model only), cohort (Third 
Generation or Omni), accelerometer wear time (valid days of use), current smoking 
status and drinks per week.  
**A bout of MVPA is defined as at least 10 minutes of continuous MVPA allowing for a 2 
minute interruption. 
Table 4: 
BMI indicates body mass index; VAT, visceral adipose tissue 
*Multivariable (MV) Model includes age, sex (in overall model only), cohort (Third 
Generation or Omni), accelerometer wear time (valid days of use), current smoking 
status and drinks per week.  
**Met MVPA Guidelines is defined as participating in ≥ 150 minutes of moderate-to-
vigorous physical activity per week. 
***Met MVPA Bout Guidelines is defined as participating in ≥ 150 minutes of moderate-
to-vigorous physical activity per week accrued in bouts of at least 10 minutes. 
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Figure 1:  Bar chart depicting the mean moderate-to-vigorous physical activity (MVPA) 
in minutes per day + standard error (SE) by Body Mass Index (BMI) categories 
according to presence or absence of hepatic steatosis.  The BMI categories are defined 
as normal BMI (BMI < 25 kg/m2), Overweight (25 kg/m2 ≤ BMI < 30 kg/m2) and Obese 
(BMI ≥ 30 kg/m2).  No hepatic steatosis represents a normal Liver Phantom Ratio (LPR) 
(LPR > 0.33) and hepatic steatosis represents an abnormal LPR (LPR ≤ 0.33). MVPA 
normal weight hepatic steatosis vs non-hepatic steatosis p=0.25; MVPA overweight 
hepatic steatosis vs non- hepatic steatosis *p=0.02; MVPA obese hepatic steatosis vs 
non-hepatic steatosis p=0.48.  
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Supplementary Material 
Patients and Methods 
Study Sample 
 The Framingham Heart Study is a multi-generational cohort study.  Beginning in 
1971, the offspring and spouses of the offspring were enrolled in the Offspring Cohort.  
Between 2002 and 2005, the grandchildren of the original cohort and children of the 
Offspring cohort were enrolled in the Third Generation Cohort.(1)  Starting in 1994, in 
order to reflect the growing ethnic diversity of the community, the Omni Cohort, which 
consists of minority residents of Framingham, MA and surrounding towns, was 
recruited.  A second Omni Cohort was recruited between 2003 and 2005, with 
examinations paralleling that of the Third Generation Cohort.  Between September 2008 
and December 2011, Offspring, Third Generation and Omni 2 Cohort participants were 
enrolled in the Multi-Detector Computed Tomography 2 substudy and underwent chest 
and abdominal computed tomographic (CT) scanning.  The median length of time 
between the CT scans and measurement of PA was 0.86 months with an interquartile 
range of 0.03 months to 4.21 months. 
Measurement of physical activity by accelerometer 
Participants were asked to remove the accelerometer only when bathing.  At the 
end of the 8 day period, participants mailed the monitor to the FHS clinic.  Data was 
visually screened for spurious data by FHS clinical staff.  Standard quality control 
metrics were applied to the data and only data from participants with a minimum of 5 of 
7 days of “valid” wear time were included in analyses as noted above.  A “valid” wear 
day was defined as a minimum of 10 hours of wear time.(2)  We used algorithms 
developed to process raw activity data from the Actical accelerometer to define 
sedentary, light, and MVPA minutes using analytical software as previously described 
(Kinesoft, version 3.3.63; KineSoft, Loughborough, UK).(3, 4)  Briefly, time spent in 
each PA category is based on the accelerometer measured “counts”  per minute which 
are calibrated to correspond to metabolic equivalents (METs) based on prior 
studies.(24)  Light-intensity activity is defined as >200 counts/minute and <3 METs, 
moderate-intensity activity as between 3-6 METs and vigorous-intensity activity as >6 
METs.(24, 25)  Sedentary time is defined as ≤200 counts/minute.  The device was 
considered not worn if there were 60 minutes of consecutive zero counts allowing for 1-
2 minute interruptions of non-zero counts.(25)  Since the accelerometer was worn for 24 
hours/day in order to maintain a high level of adherence with wearing the device, sleep 
time was defined empirically as between the hours of 2200 hours and 0600 hours and 
sedentary activity was not considered during this time period.  All other count data 
contributed to wear time.  Because the total time spent at vigorous-intensity activity was 
so small, moderate and vigorous-intensity minutes were summed to obtain the total 
MVPA time.  Based on the national PA guidelines for Americans which recommends 
that all adults participate in at least 150 minutes of MVPA per week with activity 
accumulated in bouts of ≥ 10 minutes (24), we additionally defined a bout of MVPA as 
at least 10 minutes of continuous MVPA, allowing for 2-minute interruptions to simulate 
conditions such as slowing a jog for a traffic light as has been done in prior 
research.(25)  For this investigation, we defined compliance with the national PA 
guidelines as participating in ≥ 150 minutes of MVPA over 5 to 7 days in bouts or in total 
MVPA, regardless of bout duration.     
Multi-detector CT scan protocol and measurement of VAT 
For the CT scans, participants were placed in the supine position and twenty-five 
contiguous 5-mm-thick slices (120 kVp, 400mA, gantry rotation time 500 ms, and table 
feed 3:1) covering 125 mm above S1 were obtained using an 8-slice multi-detector 
abdominal CT scanner (LightSpeed Ultra, General Electric, Milwaukee, WI).  A 
calibration phantom (Image Analysis, Lexington, KY) with a water equivalent compound 
(CT-Water, Light Speed Ultra; General Electric, Milwaukee, WI) and calcium 
hydroxyapatite at 0, 75, and 150 mg/cm3 was placed under each participant and was 
visualized on each image obtained.  Three areas from the liver, two areas from the 
spleen and one from the external phantom were measured and averaged to create liver 
spleen ratios and liver phantom ratios (LPR).  The intra-class correlation coefficient was 
0.99 on a subset of 50 randomly selected participants.  Because the spleen was not 
visualized on all scans, the liver phantom ratio was used as the indexed standard.   
VAT and subcutaneous adipose tissue (SAT) were measured using an image 
display window of -195 to -45 Hounsfield Units (HU) and a window center of -120 HU to 
identify pixels containing fat.  The VAT compartment was separated from the SAT 
compartment by a single reader who manually traced the muscular abdominal wall 
separating these depots.  VAT and SAT volumes were subsequently quantified using a 
semiautomatic segmentation technique at a dedicated offline workstation (Aquarius 3D 
Workstation; TeraRecon, San Mateo, CA) as described.(5)  The interclass correlation 
coefficients between two independent readers on a subset of 100 randomly selected 
participants were 0.992 and 0.997 for VAT and SAT, respectively.   
Covariate and baseline measurements  
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
levels were obtained from fasting morning samples using an automated Roche method 
(Roche cobas 501).  Data on ethnicity was obtained from self-administered 
questionnaires, while alcohol use and smoking status were assessed on the basis of 
physician-administrated questionnaires.  Alcohol use was recorded as drinks per week 
or drinks per month.  Participants were considered current smokers if they had smoked 
at least one cigarette per day in the year preceding the FHS examination.  
Anthropometric measurements were obtained by trained technicians using standard 
protocols for measuring height, weight and waist circumference.  BMI was defined as 
weight (kg)/height2 (m2). 
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  Supplementary Table 1:  Multivariable-adjusted logistic regressions examining the association 
between 30 minutes/day increment of sedentary time and hepatic steatosis (Liver Phantom 
Ratio ≤ 0.33). 
 Women (n=501) Men (n=559) Overall (n=1060) P Value 
for Sex 
Interaction  OR (95% CI) P 
Value 
 OR (95% CI) P 
Value 
 OR (95% CI) P 
Value 
Sedentary 
(min/day) 
      0.70 
   Multivariable 
(MV) Model* 
0.98 (0.88-1.08) 0.64 1.0 (0.92-1.09) 0.99 0.99 (0.93-1.06) 0.76  
   MV + BMI 1.0 (0.88-1.13) 0.98 1.03 (0.93-1.13) 0.62 1.02 (0.94-1.10) 0.67  
   MV + VAT 1.0 (0.88-1.14) 0.99 1.03 (0.93-1.13) 0.61 1.02 (0.94-1.10) 0.64  
BMI indicates body mass index; VAT, visceral adipose tissue 
*Multivariable (MV) Model includes age, sex (in overall model only), cohort (Third Generation or 
Omni), accelerometer wear time (valid days of use), light PA minutes/day, MVPA minutes/day, 
current smoking status and drinks per week.  
  
Supplementary Table 2:  Multivariable-adjusted linear regressions examining the associations 
between 30 minutes/day increment of physical activity and log-adjusted aminotransferase 
levels.* 
 Log-AST Log-ALT 
Beta Coefficient 
(95% CI) 
P Value Beta Coefficient 
(95% CI) 
P Value  
MVPA (min/day)     
   Multivariable (MV) 
Model** 
0.17 (0.08-0.26) 0.0002 -0.04 (-0.12-0.05) 0.41 
   MV + BMI 0.17 (0.08-0.26) 0.0002 0.02 (-0.06-0.10) 0.62 
   MV + VAT 0.18 (0.09-0.27) 0.0001 +0.04 (-0.04-0.13) 0.30 
MVPA Bouts (min/day)***     
   Multivariable (MV) 
Model** 
0.29 (0.15-0.42) <0.0001 -0.09 (-0.21-0.04) 0.18 
   MV + BMI 0.30 (0.16-0.43) <0.0001 -0.01 (-0.13-0.12) 0.91 
   MV + VAT 0.30 (0.16-0.43) <0.0001 0.00 (-0.12-0.13) 0.95 
Light (min/day)     
   Multivariable (MV) 
Model** 
0.03 (-0.01-0.06) 0.16 0.01 (-0.03-0.04) 0.71 
   MV + BMI 0.03 (-0.01-0.06) 0.16 0.01 (-0.03-0.04) 0.61 
   MV + VAT 0.03 (-0.01-0.06) 0.15 0.02 (-0.02-0.05) 0.33 
Met MVPA Guidelines****     
   Multivariable (MV) 
Model** 
0.17 (0.04-0.29) 0.008 -0.08 (-0.20-0.03) 0.17 
   MV + BMI 0.17 (0.05-0.30) 0.007 -0.00 (-0.12-0.11) 0.96 
   MV + VAT 0.17 (0.05-0.30) 0.007 0.02 (-0.09-0.13) 0.70 
Met MVPA Guidelines*****     
   Multivariable (MV) 
Model** 
0.31 (0.13-0.49) 0.0007 -0.05 (-0.22-0.12) 0.54 
   MV + BMI 0.32 (0.14-0.50) 0.0006 0.03 (-0.14-0.20) 0.72 
   MV + VAT 0.32 (0.14-0.50) 0.0006 0.04 (-0.13-0.20) 0.66 
AST indicates aspartate aminotransferase; ALT, alanine aminotransferase; BMI, body mass 
index; VAT, visceral adipose tissue 
*There were no significant sex interactions. 
**Multivariable (MV) Model includes age, sex, cohort (Third Generation or Omni), accelerometer 
wear time (valid days of use), current smoking status and drinks per week.  
***A bout of MVPA is defined as at least 10 minutes of continuous MVPA allowing for a 2 minute 
interruption. 
****Met MVPA Guidelines is defined as participating in ≥ 150 minutes of moderate-to-vigorous 
physical activity per week. 
*****Met MVPA Bout Guidelines is defined as participating in ≥ 150 minutes of moderate-to-
vigorous physical activity per week accrued in bouts of at least 10 minutes. 
 
Beta estimates provided above give standard deviation increase in log AST/ALT. 
 
